An Interpretable Model-Based Prediction of Severity and Crucial Factors in Patients with COVID-19
- PMID: 33708997
- PMCID: PMC7930914
- DOI: 10.1155/2021/8840835
An Interpretable Model-Based Prediction of Severity and Crucial Factors in Patients with COVID-19
Abstract
This study established an interpretable machine learning model to predict the severity of coronavirus disease 2019 (COVID-19) and output the most crucial deterioration factors. Clinical information, laboratory tests, and chest computed tomography (CT) scans at admission were collected. Two experienced radiologists reviewed the scans for the patterns, distribution, and CT scores of lung abnormalities. Six machine learning models were established to predict the severity of COVID-19. After parameter tuning and performance comparison, the optimal model was explained using Shapley Additive explanations to output the crucial factors. This study enrolled and classified 198 patients into mild (n = 162; 46.93 ± 14.49 years old) and severe (n = 36; 60.97 ± 15.91 years old) groups. The severe group had a higher temperature (37.42 ± 0.99°C vs. 36.75 ± 0.66°C), CT score at admission, neutrophil count, and neutrophil-to-lymphocyte ratio than the mild group. The XGBoost model ranked first among all models, with an AUC, sensitivity, and specificity of 0.924, 90.91%, and 97.96%, respectively. The early stage of chest CT, total CT score of the percentage of lung involvement, and age were the top three contributors to the prediction of the deterioration of XGBoost. A higher total score on chest CT had a more significant impact on the prediction. In conclusion, the XGBoost model to predict the severity of COVID-19 achieved excellent performance and output the essential factors in the deterioration process, which may help with early clinical intervention, improve prognosis, and reduce mortality.
Copyright © 2021 Bowen Zheng et al.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.Radiol Med. 2021 Jan;126(1):29-39. doi: 10.1007/s11547-020-01293-w. Epub 2020 Oct 12. Radiol Med. 2021. PMID: 33047295 Free PMC article.
-
Machine Learning-Based Prediction of COVID-19 Severity and Progression to Critical Illness Using CT Imaging and Clinical Data.Korean J Radiol. 2021 Jul;22(7):1213-1224. doi: 10.3348/kjr.2020.1104. Epub 2021 Mar 9. Korean J Radiol. 2021. PMID: 33739635 Free PMC article.
-
Multicenter Study of Temporal Changes and Prognostic Value of a CT Visual Severity Score in Hospitalized Patients With Coronavirus Disease (COVID-19).AJR Am J Roentgenol. 2021 Jul;217(1):83-92. doi: 10.2214/AJR.20.24044. Epub 2020 Sep 9. AJR Am J Roentgenol. 2021. PMID: 32903056
-
Correlation between lung infection severity and clinical laboratory indicators in patients with COVID-19: a cross-sectional study based on machine learning.BMC Infect Dis. 2021 Feb 18;21(1):192. doi: 10.1186/s12879-021-05839-9. BMC Infect Dis. 2021. PMID: 33602128 Free PMC article.
-
Comparing machine learning algorithms to predict COVID‑19 mortality using a dataset including chest computed tomography severity score data.Sci Rep. 2023 Jul 13;13(1):11343. doi: 10.1038/s41598-023-38133-6. Sci Rep. 2023. PMID: 37443373 Free PMC article.
Cited by
-
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563. Pathogens. 2022. PMID: 35631084 Free PMC article. Review.
-
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023. PLoS One. 2023. PMID: 37815980 Free PMC article.
-
Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.PLoS One. 2021 Oct 21;16(10):e0259006. doi: 10.1371/journal.pone.0259006. eCollection 2021. PLoS One. 2021. PMID: 34673822 Free PMC article.
-
Prevalence of comorbid tuberculosis amongst COVID-19 patients: A rapid review and meta-analysis.Int J Clin Pract. 2021 Nov;75(11):e14867. doi: 10.1111/ijcp.14867. Int J Clin Pract. 2021. PMID: 34670351 Free PMC article. Review. No abstract available.
-
Comparative Analysis of Machine Learning Methods to Predict Growth of F. sporotrichioides and Production of T-2 and HT-2 Toxins in Treatments with Ethylene-Vinyl Alcohol Films Containing Pure Components of Essential Oils.Toxins (Basel). 2021 Aug 5;13(8):545. doi: 10.3390/toxins13080545. Toxins (Basel). 2021. PMID: 34437416 Free PMC article.
References
-
- Jin Y.-H., Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM), Zhan Q.-Y., et al. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: an evidence-based clinical practice guideline (updated version) Military Medical Research. 2020;7(1):p. 41. doi: 10.1186/s40779-020-00270-8. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical